1 most recent filing and news item mentioning ARQT. Updated every 60 seconds.
LeadershipJul 16, 2026Positive
Arcutis Biotherapeutics appointed Chris Peetz to its board to support its growth strategy. The move aims to leverage his extensive experience in building and scaling biopharmaceutical organizations.
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.